BUSINESSWIRE

The complaint, filed in the United States District Court for the Southern District of California, seeks relief against the defendants for infringing SkinMedica's U.S. Patents No. 6,372,494 and/or 7,118,746. The ˜494 and ˜746 patents, which were filed in 1999 and 2000, respectively, relate to methods and uses of SkinMedica's proprietary conditioned cell media technology. The complaint also seeks relief for the misappropriation of SkinMedica trade secrets and confidential information by Histogen, Inc., Histogen Aesthetics, LLC and Dr. Naughton.

To read the complete news article from pharmalive.com click here.